The Life Ledger

Fitness is a way of life.

Fetched from Food and Drug Administration Consumer Updates

FDA issued an Early Communication on January 25, 2008, announcing that it will conduct a review of Merck/Schering Plough’s recently completed study on Vytorin (ezetimibe/simvastatin) once the agency receives the final results

Thank you for visiting The Life Ledger. If you enjoyed this article, check out the related posts below and subscribe to our feed.

Related posts:

1. New Era Canning Company Expands Nationwide Recall [Fetched Feed]
2. FDA’s Strategic Plan: Charting Our Course for the Future [Fetched Feed]
3. FDA Takes Action to Stop the Marketing of Unapproved Injectable Drugs Containing Colchicine [Fetched Feed]
4. FDA Warns Consumers about Total Body Formula [Fetched Feed]
5. FDA: Some Denture Cleansers Cause Adverse Reactions, Death [Fetched Feed]
6. FDA Announces Permanent Injunction against Food Companies, Executives [Fetched Feed]
7. Problems Digesting Dairy Products? [Fetched Feeds]
8. Orlistat / alli - FDA approves OTC loose-stool drug
9. Drug companies are fun to mock (and they deserve it, too)
10. Buying Ambien online? FDA says you’re getting an anti-psychotic.

Related posts brought to you by Yet Another Related Posts Plugin.